Paula Bresciani Martins de Andrade

Researcher at Hospital Israelita Albert Einstein, specializing in Clinical Research for the Proadi-SUS Project, focusing on AI validation in clinical settings. Served as a Scientific Writer at ADIAL Pharmaceuticals USA from November 2023 to June 2024, and as a Grant Writer at APIS Assay Technologies from December 2022 to May 2023. Worked as a Scientific Advisor at Sotelab SP in 2022 and as a Senior Project Manager at AFS - ANDRIOTTO/European Grants from 2021 to 2022. More information about this role can be found [here](https://www.andriotto.com/what-we-do/european-grants/). Served as a Scientific Advisor to the Pro-Rectory of Research and Graduate Studies at Universidade Cruzeiro do Sul between 2015 and 2018, and was a researcher with a FAPESP Young Investigator grant at the same institution from 2012 to 2015. Collaborated as a researcher with the University of São Paulo (USP - IQ and ICB) and the Federal University of São Paulo (UNIFESP - Department of Biological Sciences) from 2009 to 2018.Completed postdoctoral research at the University of Geneva (UNIGE - Faculties of Medicine and Sciences) and the University of Lausanne (UNIL - Pharmacology Department) from 2002 to 2008. Additionally, was hired as a researcher at the University of Fribourg (UNIFR - Faculty of Medicine) between 2007 and 2008.Possesses extensive experience in research and student supervision in the fields of Biochemistry, Cellular and Molecular Biology, Cellular Metabolism, and Physiology. Secured funding from FAPESP, the University of Geneva (UNIGE), and the University of Fribourg (UNIFR).Holds a Ph.D. in Biochemistry and a Bachelor's degree in Chemistry from the Institute of Chemistry at the University of São Paulo (IQ-USP). (Fonte: Currículo Lattes)